Viewing Study NCT01601704

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:18 PM
Ignite Modification Date: 2026-06-04 @ 6:55 PM
Study NCT ID: NCT01601704
Status: TERMINATED
Last Update Posted: 2017-02-27
First Post: 2012-05-14
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)
Sponsor: Orexigen Therapeutics, Inc
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Obesity View
None Overweight View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Body Weight View
None Bupropion View
None Cardiovascular Diseases View
None Diabetes Mellitus View
None Diabetes Mellitus, Type 2 View
None Endocrine System Diseases View
None Glucose Metabolism Disorders View
None Heart Diseases View
None Metabolic Diseases View
None Narcotic Antagonists View
None Naltrexone View
None Nutrition Disorders View
None Obesity View
None Overnutrition View
None Overweight View